Top Markets
Coin of the day
Laboratorio Reig Jofre, S.A. Laboratorio Reig Jofre, S.A.

Laboratorio Reig Jofre, S.A.

RJF
Rank in Stocks #17001
Laboratorio Reig Jofre, S.A. is a pharmaceutical company dedicated to the... Laboratorio Reig Jofre, S.A. is a pharmaceutical company dedicated to the research, development, manufacturing, and commercialization of a diverse range of medicines and nutritional supplements. Its extensive portfolio encompasses prescription drugs, over-the-counter (OTC) products, medical devices, and cosmetics. The company's offerings are categorized into several key areas: advanced pharmaceutical technologies, which include antibiotics and injectable formulations; specialized healthcare solutions targeting dermatological, musculoskeletal (joint health and pain), women's health, respiratory/ENT, and pediatric needs; and consumer health items marketed under its FortΓ© Pharma brand. Furthermore, Laboratorio Reig Jofre provides contract development and manufacturing (CDMO) as well as contract manufacturing organization (CMO) services. Founded in 1929 and headquartered in Sant Joan DespΓ­, Spain, the company sells its products directly in seven countries and collaborates with business partners to reach approximately 70 other nations. It operates as a subsidiary of Reig Jofre Investments SL.
Share Price
$3.20
Market Cap
$262.86M
Change (1 day)
0.00%
Change (1 year)
-1.01%
Country
ES
Trade Laboratorio Reig Jofre, S.A. (RJF)

Category

Number of shares outstanding for Laboratorio Reig Jofre, S.A. (RJF)
Number of shares outstanding as of September 2026: 0
According to Laboratorio Reig Jofre, S.A. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of September 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Laboratorio Reig Jofre, S.A. (RJF) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors